Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Baxter
Boehringer Ingelheim
QuintilesIMS
Johnson and Johnson
Chinese Patent Office
Harvard Business School
Moodys

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,288,095

« Back to Dashboard

Summary for Patent: 6,288,095
Title: Compounds
Abstract:A method is provided for the treatment and/or prophylaxis of cardiovascular diseases or eating disorders in a human or non-human mammal, which comprises administering to a human or non-human mammal in need thereof, an effective, non-toxic amount of a compound of formula (I): ##STR1## or a tautomeric form thereof and/or a pharmaceuticlaly acceptable salt thereof and/or a pharmaceutically acceptable solvate thereof, in which A.sup.1 represents a substituted or unsubstituted aromatic heterocyclyl group; R.sup.1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; R.sup.2 and R.sup.3 each represent hydrogen, or R.sup.2 and R.sup.3 together represent a bond; A.sup.2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6.
Inventor(s): Hindley; Richard Mark (Epsom, GB), Cawthorne; Michael Antony (Epsom, GB)
Assignee: Beecham Group p.l.c. (GB)
Application Number:08/358,327
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Dosage form;

Drugs Protected by US Patent 6,288,095

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,288,095

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8720825Sep 04, 1987
United Kingdom8727987Nov 30, 1987
United Kingdom8802454Feb 04, 1988

International Patents Family Members for US Patent 6,288,095

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 10199003 ➤ Try a Free Trial
Denmark 490288 ➤ Try a Free Trial
Denmark 175176 ➤ Try a Free Trial
Denmark 200001556 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Medtronic
Teva
Mallinckrodt
Baxter
Citi
Boehringer Ingelheim
Daiichi Sankyo
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.